BOSTON SCIENTIFIC CORPORATION OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax
BOSTON SCIENTIFIC CORPORATION (BSX) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax of $0 for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-07-31.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax · last filed 2018-07-31
- BOSTON SCIENTIFIC CORPORATION oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for the quarter ending 2018-03-31 was $0.00.
- BOSTON SCIENTIFIC CORPORATION oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for the quarter ending 2017-12-31 was $2.00M.
- BOSTON SCIENTIFIC CORPORATION oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for the quarter ending 2017-09-30 was $1.00M.
- BOSTON SCIENTIFIC CORPORATION oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for fiscal 2017 was $5.00M.
- BOSTON SCIENTIFIC CORPORATION oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for fiscal 2016 was -$6.00M.
- BOSTON SCIENTIFIC CORPORATION oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for fiscal 2015 was $0.00.
- BOSTON SCIENTIFIC CORPORATION oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for fiscal 2014 was $0.00.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 6 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 9 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 12 month |
|---|---|---|---|---|
| 2018-06-30 | $0.00 10-Q · filed 2018-07-31 | $0.00 10-Q · filed 2018-07-31 | $2.00M derived: sum of 3 quarters · filed 2018-07-31 | $3.00M derived: sum of 4 quarters · filed 2018-07-31 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-01 | $2.00M derived: sum of 2 quarters · filed 2018-05-01 | $3.00M derived: sum of 3 quarters · filed 2018-05-01 | $5.00M derived: sum of 4 quarters · filed 2018-07-31 |
| 2017-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $3.00M derived: sum of 2 quarters · filed 2018-02-20 | $5.00M derived: sum of 3 quarters · filed 2018-07-31 | $5.00M 10-K · filed 2018-02-20 |
| 2017-09-30 | $1.00M 10-Q · filed 2017-11-02 | $3.00M derived: sum of 2 quarters · filed 2018-07-31 | $3.00M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $2.00M 10-Q · filed 2018-07-31 | $2.00M 10-Q · filed 2018-07-31 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-01 | |||
| 2016-12-31 | -$6.00M 10-K · filed 2018-02-20 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-20 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |